| Dr Gagandeep Khurana, MD | |
|
8101 Hinson Farm Rd Ste 214, Alexandria, VA 22306-3406 | |
| (703) 386-6899 | |
| (703) 765-2000 |
| Full Name | Dr Gagandeep Khurana |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 8101 Hinson Farm Rd Ste 214, Alexandria, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104261858 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 0101258185 (Virginia) | Primary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD043017 (District Of Columbia) | Secondary |
| Entity Name | Mental Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154356244 PECOS PAC ID: 6002701356 Enrollment ID: O20040217000340 |
News Archive
Researchers studying mice are getting closer to understanding how stress affects mood and motivation for drugs.
The COVID-19 pandemic has been associated with both short- and long-term neurologic complications, including stroke, brain fog and persistent tiredness. A new study concludes that the effects of SARS-CoV-2 on the central nervous system (CNS) are due to the endothelial injury and inflammation that this produces in the brain.
Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the Octopus® Nuvo Tissue Stabilizer as a Class I recall. FDA classifies a recall as Class I when the agency believes that there is a reasonable probability that use of the recalled product will cause serious adverse health consequences or death. On Sept. 14, 2010, Medtronic proactively and voluntarily recalled the device from the market due to the potential that a component of the device could fracture during use.
The long list of side effects that follow ads for the newer expensive drugs to treat Type 2 diabetes sometimes include an unusual warning: They might cause weight loss. That side effect is one that many people — especially those with Type 2 diabetes, which is associated with obesity — may desperately want.
For a long time, scientists have dreamt of converting undesirable white fat cells into brown fat cells and thus simply have excess pounds melt away. Researchers at the University of Bonn have now gotten a step closer to this goal: They decoded a "toggle switch" in mice which can significantly stimulate fat burning.
› Verified 9 days ago
| Entity Name | Holisticare Behavioral Health Svs Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588274435 PECOS PAC ID: 8527426519 Enrollment ID: O20230623000853 |
News Archive
Researchers studying mice are getting closer to understanding how stress affects mood and motivation for drugs.
The COVID-19 pandemic has been associated with both short- and long-term neurologic complications, including stroke, brain fog and persistent tiredness. A new study concludes that the effects of SARS-CoV-2 on the central nervous system (CNS) are due to the endothelial injury and inflammation that this produces in the brain.
Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the Octopus® Nuvo Tissue Stabilizer as a Class I recall. FDA classifies a recall as Class I when the agency believes that there is a reasonable probability that use of the recalled product will cause serious adverse health consequences or death. On Sept. 14, 2010, Medtronic proactively and voluntarily recalled the device from the market due to the potential that a component of the device could fracture during use.
The long list of side effects that follow ads for the newer expensive drugs to treat Type 2 diabetes sometimes include an unusual warning: They might cause weight loss. That side effect is one that many people — especially those with Type 2 diabetes, which is associated with obesity — may desperately want.
For a long time, scientists have dreamt of converting undesirable white fat cells into brown fat cells and thus simply have excess pounds melt away. Researchers at the University of Bonn have now gotten a step closer to this goal: They decoded a "toggle switch" in mice which can significantly stimulate fat burning.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gagandeep Khurana, MD 8101 Hinson Farm Rd Ste 214, Alexandria, VA 22306-3406 Ph: (703) 386-6899 | Dr Gagandeep Khurana, MD 8101 Hinson Farm Rd Ste 214, Alexandria, VA 22306-3406 Ph: (703) 386-6899 |
News Archive
Researchers studying mice are getting closer to understanding how stress affects mood and motivation for drugs.
The COVID-19 pandemic has been associated with both short- and long-term neurologic complications, including stroke, brain fog and persistent tiredness. A new study concludes that the effects of SARS-CoV-2 on the central nervous system (CNS) are due to the endothelial injury and inflammation that this produces in the brain.
Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the Octopus® Nuvo Tissue Stabilizer as a Class I recall. FDA classifies a recall as Class I when the agency believes that there is a reasonable probability that use of the recalled product will cause serious adverse health consequences or death. On Sept. 14, 2010, Medtronic proactively and voluntarily recalled the device from the market due to the potential that a component of the device could fracture during use.
The long list of side effects that follow ads for the newer expensive drugs to treat Type 2 diabetes sometimes include an unusual warning: They might cause weight loss. That side effect is one that many people — especially those with Type 2 diabetes, which is associated with obesity — may desperately want.
For a long time, scientists have dreamt of converting undesirable white fat cells into brown fat cells and thus simply have excess pounds melt away. Researchers at the University of Bonn have now gotten a step closer to this goal: They decoded a "toggle switch" in mice which can significantly stimulate fat burning.
› Verified 9 days ago
Dr. Nicholas Randall Morris, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2050 Ballenger Ave, Maia Institute, Alexandria, VA 22314 Phone: 301-500-0645 | |
Dr. Kevin Michael Williams, MD, MBA Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3737 Seminary Rd, Alexandria, VA 22304 Phone: 703-283-8679 Fax: 703-461-3448 | |
Dr. Rama Prayaga, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5194 Dawes Ave, Alexandria, VA 22311 Phone: 703-820-1900 Fax: 866-528-6229 | |
Dr. Israel M Labao Jr., M.D., M.P.H. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6910 Richmond Hwy Ste 110, Alexandria, VA 22306 Phone: 703-660-8100 Fax: 703-768-0103 | |
Dr. Simona Pick Both, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8119 Holland Rd, Alexandria, VA 22306 Phone: 703-383-8500 | |
Dr. James Thomas Thornburgh, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8119 Holland Rd, Alexandria, VA 22306 Phone: 703-799-2762 | |
Dr. Abdorasool Janati, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2863 Duke St, Alexandria, VA 22314 Phone: 703-801-7745 |